8
IRUS TotalDownloads
Altmetric
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 656.18 kB | Adobe PDF | View/Open |
Title: | Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study |
Authors: | Behary, P Alessimii, H Miras, AD Tharakan, G Alexiadou, K Aldhwayan, MM Purkayastha, S Moorthy, K Ahmed, AR Bloom, SR Tan, TM |
Item Type: | Journal Article |
Abstract: | Aims To investigate whether the elevation in postprandial concentrations of the gut hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM) and peptide YY (PYY) accounts for the beneficial changes in food preferences, sweet taste function and eating behaviour after Roux-en-Y gastric bypass (RYGB). Materials and methods This was a secondary analysis of a randomized single-blind study in which we infused GLP-1, OXM, PYY (GOP) or 0.9% saline subcutaneously for 4 weeks in 24 subjects with obesity and prediabetes/diabetes, to replicate their peak postprandial concentrations, as measured at 1 month in a matched RYGB cohort (ClinicalTrials.gov NCT01945840). A 4-day food diary and validated eating behaviour questionnaires were completed. Sweet taste detection was measured using the method of constant stimuli. Correct sucrose identification (corrected hit rates) was recorded, and sweet taste detection thresholds (EC50s: half maximum effective concencration values) were derived from concentration curves. The intensity and consummatory reward value of sweet taste were assessed using the generalized Labelled Magnitude Scale. Results Mean daily energy intake was reduced by 27% with GOP but no significant changes in food preferences were observed, whereas a reduction in fat and increase in protein intake were seen post-RYGB. There was no change in corrected hit rates or detection thresholds for sucrose detection following GOP infusion. Additionally, GOP did not alter the intensity or consummatory reward value of sweet taste. A significant reduction in restraint eating, comparable to the RYGB group was observed with GOP. Conclusion The elevation in plasma GOP concentrations after RYGB is unlikely to mediate changes in food preferences and sweet taste function after surgery but may promote restraint eating. |
Issue Date: | Jun-2023 |
Date of Acceptance: | 19-Feb-2023 |
URI: | http://hdl.handle.net/10044/1/104349 |
DOI: | 10.1111/dom.15028 |
ISSN: | 1462-8902 |
Publisher: | Wiley |
Start Page: | 1731 |
End Page: | 1739 |
Journal / Book Title: | Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics |
Volume: | 25 |
Issue: | 6 |
Copyright Statement: | © 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
Sponsor/Funder: | Medical Research Council (MRC) |
Funder's Grant Number: | MR/K02115X/1 |
Keywords: | Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism antiobesity drug bariatric surgery GLP-1 obesity therapy randomized trial weight control GASTRIC BYPASS-SURGERY VERTICAL BANDED GASTROPLASTY GLUCAGON-LIKE PEPTIDE-1 WEIGHT-LOSS BARIATRIC SURGERY MORBIDLY OBESE HEDONIC HUNGER GLP-1 RESPONSE BRAIN ACTIVITY DIETARY-INTAKE GLP-1 antiobesity drug bariatric surgery obesity therapy randomized trial weight control Humans Taste Food Preferences Single-Blind Method Prediabetic State Obesity Gastric Bypass Gastrointestinal Hormones Peptide YY Glucagon-Like Peptide 1 Sucrose Volunteers Humans Prediabetic State Obesity Gastrointestinal Hormones Peptide YY Sucrose Gastric Bypass Single-Blind Method Food Preferences Taste Glucagon-Like Peptide 1 Volunteers antiobesity drug bariatric surgery BARIATRIC SURGERY BRAIN ACTIVITY DIETARY-INTAKE Endocrinology & Metabolism GASTRIC BYPASS-SURGERY GLP-1 GLP-1 RESPONSE GLUCAGON-LIKE PEPTIDE-1 HEDONIC HUNGER Life Sciences & Biomedicine MORBIDLY OBESE obesity therapy randomized trial Science & Technology VERTICAL BANDED GASTROPLASTY weight control WEIGHT-LOSS 1103 Clinical Sciences Endocrinology & Metabolism |
Publication Status: | Published |
Online Publication Date: | 2023-02-22 |
Appears in Collections: | Department of Metabolism, Digestion and Reproduction Department of Surgery and Cancer |
This item is licensed under a Creative Commons License